Dr. David Elashoff's primary area of statistical research is in the design and analysis of high-throughput microarray and proteomic studies. He also has a strong interest in the methodology for the design and analysis of biomarker discovery and validation studies. Elashoff has extensive experience working on cancer related projects with collaborations in lung, head and neck, prostate, breast, pancreatic, colon and skin cancers. These collaborations include basic science, biomarker discovery, translational research and clinical trials.
Mendelsohn AH, Lai CK, Shintaku IP, Fishbein MC, Brugman K, Elashoff DA, Abemayor E, Dubinett SM, St John MA. Snail as a novel marker for regional metastasis in head and neck squamous cell carcinoma. Am J Otolaryngol. 2012 Jan-Feb;33(1):6-13. doi: 10.1016/j.amjoto.2010.11.018. Epub 2011 Mar 24.
Mao JT, Roth MD, Fishbein MC, Aberle DR, Zhang ZF, Rao JY, Tashkin DP, Goodglick L, Holmes EC, Cameron RB, Dubinett SM, Elashoff R, Szabo E, Elashoff D. Lung cancer chemoprevention with celecoxib in former smokers. Cancer Prev Res (Phila). 2011 Jul;4(7):984-93.
Sarna L, Cooley ME, Brown JK, Chernecky C, Padilla G, Danao L, Chakravarty D, Elashoff D. Women with lung cancer: quality of life after thoracotomy: a 6-month prospective study. Cancer Nurs. 2010 Mar-Apr;33(2):85-92.
Li Y, St John MA, Zhou X, Kim Y, Sinha U, Jordan RC, Eisele D, Abemayor E, Elashoff D, Park NH, Wong DT. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res. 2004 Dec 15;10(24):8442-50.